Medpace Holdings, Inc. 8-K

What Happened

• Medpace Holdings, Inc. announced its financial results for the three and twelve months ended December 31, 2025 in a press release dated February 9, 2026. The company filed a Form 8-K (Item 2.02) furnishing that press release as Exhibit 99.1 and posted the full text on its website.

Key Details

• Filing date: February 9, 2026 (Form 8-K).
• Reporting periods: three and twelve months ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the 8-K and posted on Medpace’s investor website.
• Form 8-K signed by Kevin M. Brady, Chief Financial Officer.

Why It Matters

• This filing notifies investors that Medpace has released its quarterly and full-year earnings information; the press release will contain revenue, earnings, and other performance metrics that can affect valuation and trading decisions.
• Investors should review the Exhibit 99.1 press release (available in the 8-K and on Medpace’s website) for the specific financial results and management commentary to assess company performance and guidance.